AzTrials
AzTrials

Premenstrual SyndromeNCT07118553

Factors Affecting Premenstrual Syndrome

A study testing classic facial massage in people with Premenstrual Syndrome, run by Trabzon University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Premenstrual pain syndrome is a common problem that affects many women of reproductive age. In this study, we aimed to determine whether facial massage would improve the quality of life, mood, pain and stress levels of women with premenstrual syndrome. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Premenstrual Syndrome
What is being tested?
classic facial massage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
27 participants
Where
1 siteTurkey (Türkiye)
Study dates
14 May 2025to 20 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • at least 111 points or more on the Premenstrual Syndrome Scale
  • 8 years of age or older
  • to be volunteer for the study

Who cannot join

  • presence of any open wounds, allergies, etc. that would prevent facial massage
  • the presence of routinely used gynaecological medication
  • regular exercise
  • unwillingness to participate

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Trabzon Unversity

    Trabzon, Tonya

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Facial Massage on Quality of Life, Mood, Pain and Stress Levels in Women With Premenstrual Syndrome

Premenstrual pain syndrome is a common problem that affects many women of reproductive age. In this study, we aimed to determine whether facial massage would improve the quality of life, mood, pain and stress levels of women with premenstrual syndrome.

Read the detailed description

Young women over the age of 18 with premenstrual syndrome were randomly divided into two groups. One group received facial massage for six weeks, while the other group received no intervention. At the end of six weeks, pain, stress, quality of life and mood were assessed in both groups.

Being tested
classic facial massage
Keywords
premenstrual syndrome, face, massage, quality of life
Medical subject headings
Premenstrual Syndrome, Facies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • classic facial massageOther

    Powder was used as an intermediate product in facial massage application. Before the application, the participants were made to lie in the supine position on the patient's bed. The researchers performed the facial massage by standing at the participants' bedside. During the massage application, three stroking movements were applied to the chin, mouth, nose, eyes and forehead areas, respectively. Kneading motion was then applied to the same areas three times each. Then, stroking was applied to these five areas again and the facial massage application was terminated at the end of approximately 20-30 minutes. Friction movement was applied to the temporal region in each stroking and kneading application

Study groups in NCT07118553
Study groupRoleWhat they receive
Facial massage groupExperimentalClassical facial massage was applied to the intervention group 2 days a week (with at least 1 day break) for 6 weeks. A session continued 20-30 minutes.
Receives: Other: classic facial massage
control groupNo interventionThe control group received no intervention. Participants continued their daily routines as usual.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale (VAS)

    The VAS was used to assess participants' pain intensity. The VAS is a scale ranging from 0 ('No pain') to 10 points ('Unbearable pain') on a horizontal line. According to the VAS, '0' means no pain, while 10 points means severe pain.

    Measured: six weeks

Secondary outcomes (3)
  1. Perceived Stress Scale (PSS)

    PSS 5-point Likert-type scale ranging from 'Never (0)' to 'Very often (4)'

    • PSS-10 takes a value between 0 and 40 points and a high score indicates a high level of stress PSS 5-point Likert-type scale ranging from 'Never (0)' to 'Very often (4)'
    • PSS-10 takes a value between 0 and 40 points and a high score indicates a high level of stress 5-point Likert-type scale ranging from 'Never (0)' to 'Very often (4)'
    • PSS-10 takes a value between 0 and 40 points and a high score indicates a high level of stress PSS is a 5-point Likert-type scale ranging from 'Never (0)' to 'Very often (4). Minimum score of the scale is 0 while the maximum score is 40. High scores indicates a high level of stress.

    Measured: six weeks

  2. Short Form-12

    It is a short version of the Short Form-36 scale and it evaluates quality of life. An increase in the obtained score indicates a good quality of life.

    Measured: six weeks

  3. Profile of Mood States (POMS):

    POMS is a 5-point Likert scale and the response to each item is scored as never (0 points), very little (1 point), moderately (2 points), quite a lot (3 points), extremely (4 points). The total scale score is obtained by subtracting the score of the vigour-activity subscale from the total score of the other items. A high score indicates the presence of a mood disorder.

    Measured: six weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2025
  2. Study start14 May 2025
  3. Primary completion20 Jun 2025
  4. Study completion20 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
two groups (intervention and control groups)
Masking
Single blind
Who is masked
Participant
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07118553
Sponsor's protocol ID
TU-TMYO-AYŞ-01
Status last verified
Aug 2025
First submitted
5 Aug 2025
Last updated
12 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing classic facial massage in people with Premenstrual Syndrome, run by Trabzon University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale (VAS) (time frame: six weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in